Literature DB >> 22637474

Investigating substrate promiscuity in cyclooxygenase-2: the role of Arg-120 and residues lining the hydrophobic groove.

Alex J Vecchio1, Benjamin J Orlando, Ritwik Nandagiri, Michael G Malkowski.   

Abstract

The cyclooxygenases (COX-1 and COX-2) generate prostaglandin H(2) from arachidonic acid (AA). In its catalytically productive conformation, AA binds within the cyclooxygenase channel with its carboxylate near Arg-120 and Tyr-355 and ω-end located within a hydrophobic groove above Ser-530. Although AA is the preferred substrate for both isoforms, COX-2 can oxygenate a broad spectrum of substrates. Mutational analyses have established that an interaction of the carboxylate of AA with Arg-120 is required for high affinity binding by COX-1 but not COX-2, suggesting that hydrophobic interactions between the ω-end of substrates and cyclooxygenase channel residues play a significant role in COX-2-mediated oxygenation. We used structure-function analyses to investigate the role that Arg-120 and residues lining the hydrophobic groove play in the binding and oxygenation of substrates by murine (mu) COX-2. Mutations to individual amino acids within the hydrophobic groove exhibited decreased rates of oxygenation toward AA with little effect on binding. R120A muCOX-2 oxygenated 18-carbon ω-6 and ω-3 substrates albeit at reduced rates, indicating that an interaction with Arg-120 is not required for catalysis. Structural determinations of Co(3+)-protoporphyrin IX-reconstituted muCOX-2 with α-linolenic acid and G533V muCOX-2 with AA indicate that proper bisallylic carbon alignment is the major determinant for efficient substrate oxygenation by COX-2. Overall, these findings implicate Arg-120 and hydrophobic groove residues as determinants that govern proper alignment of the bisallylic carbon below Tyr-385 for catalysis in COX-2 and confirm nuances between COX isoforms that explain substrate promiscuity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22637474      PMCID: PMC3397890          DOI: 10.1074/jbc.M112.372243

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Dietary long chain n-3 fatty acids are more closely associated with protein than energy intakes from fat.

Authors:  E M Novak; S M Innis
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-02-10       Impact factor: 4.006

Review 2.  Structural and functional basis of cyclooxygenase inhibition.

Authors:  Anna L Blobaum; Lawrence J Marnett
Journal:  J Med Chem       Date:  2007-03-07       Impact factor: 7.446

3.  Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2.

Authors:  C Luong; A Miller; J Barnett; J Chow; C Ramesha; M F Browner
Journal:  Nat Struct Biol       Date:  1996-11

4.  The binding of arachidonic acid in the cyclooxygenase active site of mouse prostaglandin endoperoxide synthase-2 (COX-2). A putative L-shaped binding conformation utilizing the top channel region.

Authors:  S W Rowlinson; B C Crews; C A Lanzo; L J Marnett
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

5.  Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer.

Authors:  Liang Dong; Alex J Vecchio; Narayan P Sharma; Brice J Jurban; Michael G Malkowski; William L Smith
Journal:  J Biol Chem       Date:  2011-04-05       Impact factor: 5.157

Review 6.  The importance of the ratio of omega-6/omega-3 essential fatty acids.

Authors:  A P Simopoulos
Journal:  Biomed Pharmacother       Date:  2002-10       Impact factor: 6.529

7.  Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1.

Authors:  D K Bhattacharyya; M Lecomte; C J Rieke; M Garavito; W L Smith
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

Review 8.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

Review 9.  Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways.

Authors:  Carol A Rouzer; Lawrence J Marnett
Journal:  Chem Rev       Date:  2011-09-19       Impact factor: 60.622

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  20 in total

1.  Revealing the macromolecular targets of complex natural products.

Authors:  Daniel Reker; Anna M Perna; Tiago Rodrigues; Petra Schneider; Michael Reutlinger; Bettina Mönch; Andreas Koeberle; Christina Lamers; Matthias Gabler; Heinrich Steinmetz; Rolf Müller; Manfred Schubert-Zsilavecz; Oliver Werz; Gisbert Schneider
Journal:  Nat Chem       Date:  2014-11-02       Impact factor: 24.427

Review 2.  Interactions of fatty acids, nonsteroidal anti-inflammatory drugs, and coxibs with the catalytic and allosteric subunits of cyclooxygenases-1 and -2.

Authors:  William L Smith; Michael G Malkowski
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

3.  Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscs.

Authors:  Benjamin J Orlando; Daniel R McDougle; Michael J Lucido; Edward T Eng; Leigh Ann Graham; Claus Schneider; David L Stokes; Aditi Das; Michael G Malkowski
Journal:  Arch Biochem Biophys       Date:  2014-02-03       Impact factor: 4.013

4.  Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.

Authors:  Liang Dong; Narayan P Sharma; Brice J Jurban; William L Smith
Journal:  J Biol Chem       Date:  2013-08-16       Impact factor: 5.157

5.  Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site.

Authors:  Michael C Goodman; Shu Xu; Carol A Rouzer; Surajit Banerjee; Kebreab Ghebreselasie; Marco Migliore; Daniele Piomelli; Lawrence J Marnett
Journal:  J Biol Chem       Date:  2018-01-11       Impact factor: 5.157

6.  Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry.

Authors:  Michael J Lucido; Benjamin J Orlando; Alex J Vecchio; Michael G Malkowski
Journal:  Biochemistry       Date:  2016-02-19       Impact factor: 3.162

7.  Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit.

Authors:  Liang Dong; Chong Yuan; Benjamin J Orlando; Michael G Malkowski; William L Smith
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

8.  The crystal structure of α-Dioxygenase provides insight into diversity in the cyclooxygenase-peroxidase superfamily.

Authors:  Christopher C Goulah; Guangyu Zhu; Mary Koszelak-Rosenblum; Michael G Malkowski
Journal:  Biochemistry       Date:  2013-02-14       Impact factor: 3.162

9.  Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.

Authors:  Shu Xu; Daniel J Hermanson; Surajit Banerjee; Kebreab Ghebreselasie; Gina M Clayton; R Michael Garavito; Lawrence J Marnett
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

10.  A Revised Mechanism for Human Cyclooxygenase-2.

Authors:  Yi Liu; Justine P Roth
Journal:  J Biol Chem       Date:  2015-11-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.